Many experts now predict that COVID-19, which so far has killed more than 5.5 million people worldwide, will remain endemic as new, infectious variants of SARS-CoV-2 emerge. These new variants could pose a greater risk of reinfection — infecting people who have already had COVID19 — than previous ones. The rapid identification of reinfection cases and surges could improve public health responses and reveal variants that escape the protection offered by vaccination.
Related Posts
Unraveling PCOS Molecular Mechanisms
Researchers are delving into the intricate world of Polycystic Ovary Syndrome (PCOS) to uncover potential treatment targets. Their study focuses on the BBOX1-AS1/miR-19b interaction, shedding light on how these non-coding RNAs impact PCOS. Involving 80 PCOS patients, this research reveals that BBOX1-AS1 is significantly upregulated in PCOS, while miR-19b is downregulated. Interestingly, BBOX1-AS1 directly interacts […]
Utilizing T-DNA concatenation to regulate gene editing
T-DNA concatenation is the process of linking multiple copies of T-DNA together. It can be used to regulate gene editing by increasing the frequency of targeted mutagenesis, creating gene traps, or creating conditional gene knockouts.
Advancing CRISPR/Cas Biosensors for Disease Detection & Treatment
CRISPR/Cas technology’s endonuclease activity has spurred genome editing, bioanalytical sensors, and disease diagnostics, notably for SARS-CoV-2 variants. Multiplexing capabilities enable sensitive detection of nucleic acids, proteins, and more. Despite successes, challenges persist, like limited multiplexing assays and off-target effects. Microfluidic integration shows promise but complexity delays immediate application. Spectral limitations in fluorescence-based assays hinder biomolecule […]